AU Patent

AU2008241013B2 — Titration of tapentadol

Assigned to Gruenenthal GmbH · Expires 2013-06-20 · 13y expired

What this patent protects

The invention relates to the use of tapentadol for the manufacture of a medicament comprising at least one administration unit A containing dose a of tapentadol and at least one administration unit B containing dose b of tapentadol, where dose a < dose b, for the treatment of …

USPTO Abstract

The invention relates to the use of tapentadol for the manufacture of a medicament comprising at least one administration unit A containing dose a of tapentadol and at least one administration unit B containing dose b of tapentadol, where dose a < dose b, for the treatment of pain.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008241013B2
Jurisdiction
AU
Classification
—
Expires
2013-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Gruenenthal GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.